Basic Information
| RNALocate ID: | RLID:11001902 |
| RNA Symbol: | hsa-miR-146a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-146a |
| RNA ID: | miRBase:MIMAT0000449 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21670082 |
| Tissue/Cell Line: | Renal cancer cells |
| Method: | qRT-PCR|TaqMan miRNA assay |
| Condition: | Human CD105+ and CD105- renal carcinomas cells |
| Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001827 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
| RLID:01001828 | Mitochondrion | Osteosarcoma cell line (143B) | 27396686 |
| RLID:01001829 | Mitochondrion | Osteosarcoma cell line (143B) | 27563705 |
| RLID:01001830 | Mitochondrion | Human umbilical vein endothelial cells | 30348904 |
| RLID:11001900 | Exosome | Plasma | 19289371 |
| RLID:11001901 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11001903 | Exosome | Breast milk | 22211110 |
| RLID:11001904 | Exosome | Brain tissue | 23382797 |
| RLID:11001905 | Exosome | Plasma | 23663360 |
| RLID:11001906 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001907 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11001908 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001909 | Microvesicle | Plasma | 23077538 |
| RLID:11001910 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001911 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001912 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000097 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000377 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-146a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-15282 |
| MNDR | hsa-miR-146a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-15283 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-15284 |
| MNDR | hsa-miR-146a-5p | Oral squamous cell carcinoma | MNDR-E-MI-15285 |
| MNDR | hsa-miR-146a-5p | Medulloblastoma | MNDR-E-MI-15286 |
| MNDR | hsa-miR-146a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-15287 |
| MNDR | hsa-miR-146a-5p | Lymphoma | MNDR-E-MI-15288 |
| MNDR | hsa-miR-146a-5p | Lymphoma non-hodgkin | MNDR-E-MI-15289 |
| MNDR | hsa-miR-146a-5p | Cutaneous t cell lymphoma | MNDR-E-MI-15290 |
| MNDR | hsa-miR-146a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15291 |
| MNDR | hsa-miR-146a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-15292 |
| MNDR | hsa-miR-146a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15293 |
| MNDR | hsa-miR-146a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15294 |
| MNDR | hsa-miR-146a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-15295 |
| MNDR | hsa-miR-146a-5p | Triple negative breast cancer | MNDR-E-MI-15296 |
| MNDR | hsa-miR-146a-5p | Colitis | MNDR-E-MI-15297 |
| MNDR | hsa-miR-146a-5p | Acute promyelocytic leukemia | MNDR-E-MI-15298 |
| MNDR | hsa-miR-146a-5p | Breast cancer luminal | MNDR-E-MI-15299 |
| MNDR | hsa-miR-146a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15300 |
| MNDR | hsa-miR-146a-5p | Anaplastic thyroid carcinoma | MNDR-E-MI-15301 |
| MNDR | hsa-miR-146a-5p | Dermatomyositis | MNDR-E-MI-15302 |
| MNDR | hsa-miR-146a-5p | Castration-resistant prostate cancer | MNDR-E-MI-15303 |
| MNDR | hsa-miR-146a-5p | Hirschsprung disease | MNDR-E-MI-15304 |
| MNDR | hsa-miR-146a-5p | Gastric cancer | MNDR-E-MI-15305 |
| MNDR | hsa-miR-146a-5p | Gastric lymphoma | MNDR-E-MI-15306 |
| MNDR | hsa-miR-146a-5p | Alzheimer disease | MNDR-E-MI-15307 |
| MNDR | hsa-miR-146a-5p | Intracranial aneurysm | MNDR-E-MI-15308 |
| MNDR | hsa-miR-146a-5p | Urinary bladder cancer | MNDR-E-MI-15309 |
| MNDR | hsa-miR-146a-5p | Esophageal carcinoma | MNDR-E-MI-15310 |
| MNDR | hsa-miR-146a-5p | Osteoporosis | MNDR-E-MI-15311 |
| MNDR | hsa-miR-146a-5p | Dysautonomia familial | MNDR-E-MI-15312 |
| MNDR | hsa-miR-146a-5p | Familial hyperlipidemia | MNDR-E-MI-15313 |
| MNDR | hsa-miR-146a-5p | Seizures | MNDR-E-MI-15314 |
| MNDR | hsa-miR-146a-5p | Head and neck cancer | MNDR-E-MI-15315 |
| MNDR | hsa-miR-146a-5p | Creutzfeldt-jakob syndrome | MNDR-E-MI-15316 |
| MNDR | hsa-miR-146a-5p | Dengue disease | MNDR-E-MI-15317 |
| MNDR | hsa-miR-146a-5p | Vogt-koyanagi-harada disease | MNDR-E-MI-15318 |
| MNDR | hsa-miR-146a-5p | Huntington disease | MNDR-E-MI-15319 |
| MNDR | hsa-miR-146a-5p | Chorea | MNDR-E-MI-15320 |
| MNDR | hsa-miR-146a-5p | Cardiovascular disease | MNDR-E-MI-15321 |
| MNDR | hsa-miR-146a-5p | Carotid stenosis | MNDR-E-MI-15322 |
| MNDR | hsa-miR-146a-5p | Moyamoya disease | MNDR-E-MI-15323 |
| MNDR | hsa-miR-146a-5p | Lung cancer | MNDR-E-MI-15324 |
| MNDR | hsa-miR-146a-5p | Giant cell arteritis | MNDR-E-MI-15325 |
| MNDR | hsa-miR-146a-5p | Tuberous sclerosis | MNDR-E-MI-15326 |
| MNDR | hsa-miR-146a-5p | Parkinson disease | MNDR-E-MI-15327 |
| MNDR | hsa-miR-146a-5p | Basal-like breast cancer | MNDR-E-MI-15328 |
| MNDR | hsa-miR-146a-5p | Vascular diseases | MNDR-E-MI-15329 |
| MNDR | hsa-miR-146a-5p | Thyroid cancer | MNDR-E-MI-15330 |
| MNDR | hsa-miR-146a-5p | Pituitary neoplasms | MNDR-E-MI-15331 |
| MNDR | hsa-miR-146a-5p | Pancreatic cancer | MNDR-E-MI-15332 |
| MNDR | hsa-miR-146a-5p | Epilepsy | MNDR-E-MI-15333 |
| MNDR | hsa-miR-146a-5p | Hepatitis C | MNDR-E-MI-15334 |
| MNDR | hsa-miR-146a-5p | Melanoma | MNDR-E-MI-15335 |
| MNDR | hsa-miR-146a-5p | Atherosclerosis | MNDR-E-MI-15336 |
| MNDR | hsa-miR-146a-5p | Rectum adenocarcinoma | MNDR-E-MI-15337 |
| MNDR | hsa-miR-146a-5p | Nephroblastoma | MNDR-E-MI-15338 |
| MNDR | hsa-miR-146a-5p | Colon cancer | MNDR-E-MI-15339 |
| MNDR | hsa-miR-146a-5p | Ischemic attack transient | MNDR-E-MI-15340 |
| MNDR | hsa-miR-146a-5p | Colon adenocarcinoma | MNDR-E-MI-15341 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis | MNDR-E-MI-15342 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15343 |
| MNDR | hsa-miR-146a-5p | Familial ovarian cancer | MNDR-E-MI-15344 |
| MNDR | hsa-miR-146a-5p | Dermatitis | MNDR-E-MI-15345 |
| MNDR | hsa-miR-146a-5p | Pulmonary tuberculosis | MNDR-E-MI-15346 |
| MNDR | hsa-miR-146a-5p | Glioblastoma | MNDR-E-MI-15347 |
| MNDR | hsa-miR-146a-5p | Astrocytoma | MNDR-E-MI-15348 |
| MNDR | hsa-miR-146a-5p | Glioma | MNDR-E-MI-15349 |
| MNDR | hsa-miR-146a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-15350 |
| MNDR | hsa-miR-146a-5p | Gastrointestinal system cancer | MNDR-E-MI-15351 |
| MNDR | hsa-miR-146a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-15352 |
| MNDR | hsa-miR-146a-5p | Epilepsy temporal lobe | MNDR-E-MI-15353 |
| MNDR | hsa-miR-146a-5p | Osteosarcoma | MNDR-E-MI-15354 |
| MNDR | hsa-miR-146a-5p | Inclusion body myositis | MNDR-E-MI-15355 |
| MNDR | hsa-miR-146a-5p | Infarction middle cerebral artery | MNDR-E-MI-15356 |
| MNDR | hsa-miR-146a-5p | Meningioma | MNDR-E-MI-15357 |
| MNDR | hsa-miR-146a-5p | Liver cancer | MNDR-E-MI-15358 |
| MNDR | hsa-miR-146a-5p | Uterine cancer | MNDR-E-MI-15359 |
| MNDR | hsa-miR-146a-5p | Gastric adenocarcinoma | MNDR-E-MI-15360 |
| MNDR | hsa-miR-146a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-15361 |
| MNDR | hsa-miR-146a-5p | Pituitary adenoma | MNDR-E-MI-15362 |
| MNDR | hsa-miR-146a-5p | Lung squamous cell carcinoma | MNDR-E-MI-15363 |
| MNDR | hsa-miR-146a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-15364 |
| MNDR | hsa-miR-146a-5p | Lung adenocarcinoma | MNDR-E-MI-15365 |
| MNDR | hsa-miR-146a-5p | Adrenocortical carcinoma | MNDR-E-MI-15366 |
| MNDR | hsa-miR-146a-5p | Thyroid carcinoma | MNDR-E-MI-15367 |
| MNDR | hsa-miR-146a-5p | Papillary thyroid carcinoma | MNDR-E-MI-15368 |
| MNDR | hsa-miR-146a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-15369 |
| MNDR | hsa-miR-146a-5p | Hypersensitivity reaction type ii disease | MNDR-E-MI-15370 |
| MNDR | hsa-miR-146a-5p | Brain stem cancer | MNDR-E-MI-15371 |
| MNDR | hsa-miR-146a-5p | Coronary restenosis | MNDR-E-MI-15372 |
| MNDR | hsa-miR-146a-5p | Gerstmann-straussler-scheinker disease | MNDR-E-MI-15373 |
| MNDR | hsa-miR-146a-5p | Cervical cancer | MNDR-E-MI-15374 |
| MNDR | hsa-miR-146a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-15375 |
| MNDR | hsa-miR-146a-5p | Carcinoma renal cell | MNDR-E-MI-15376 |
| MNDR | hsa-miR-146a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15377 |
| MNDR | hsa-miR-146a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-15378 |
| MNDR | hsa-miR-146a-5p | Biliary tract cancer | MNDR-E-MI-15379 |
| MNDR | hsa-miR-146a-5p | Medulloepithelioma | MNDR-E-MI-15380 |
| MNDR | hsa-miR-146a-5p | Cholangiocarcinoma | MNDR-E-MI-15381 |
| MNDR | hsa-miR-146a-5p | Esophageal cancer | MNDR-E-MI-15382 |
| MNDR | hsa-miR-146a-5p | Scrapie | MNDR-E-MI-15383 |
| MNDR | hsa-miR-146a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-15384 |
| MNDR | hsa-miR-146a-5p | Acute t cell leukemia | MNDR-E-MI-15385 |
| MNDR | hsa-miR-146a-5p | Heart failure | MNDR-E-MI-15386 |
| MNDR | hsa-miR-146a-5p | Fibromyalgia | MNDR-E-MI-15387 |
| MNDR | hsa-miR-146a-5p | Pulmonary hypertension | MNDR-E-MI-15388 |
| MNDR | hsa-miR-146a-5p | Cerebrovascular disease | MNDR-E-MI-15389 |
| MNDR | hsa-miR-146a-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-15390 |
| MNDR | hsa-miR-146a-5p | Hepatocellular carcinoma | MNDR-E-MI-15391 |
| MNDR | hsa-miR-146a-5p | Familiar ovarian carcinoma | MNDR-E-MI-15392 |
| MNDR | hsa-miR-146a-5p | B-cell lymphoma | MNDR-E-MI-15393 |
| MNDR | hsa-miR-146a-5p | Ankylosing spondylitis | MNDR-E-MI-15394 |
| MNDR | hsa-miR-146a-5p | Rheumatoid arthritis | MNDR-E-MI-15395 |
| MNDR | hsa-miR-146a-5p | T-cell leukemia | MNDR-E-MI-15396 |
| MNDR | hsa-miR-146a-5p | Retinoblastoma | MNDR-E-MI-15397 |
| MNDR | hsa-miR-146a-5p | Neuroblastoma | MNDR-E-MI-15398 |
| MNDR | hsa-miR-146a-5p | Chronic fatigue syndrome | MNDR-E-MI-15399 |
| MNDR | hsa-miR-146a-5p | Hodgkin disease | MNDR-E-MI-15400 |
| MNDR | hsa-miR-146a-5p | Ulcerative colitis | MNDR-E-MI-15401 |
| MNDR | hsa-miR-146a-5p | Burkitt lymphoma | MNDR-E-MI-15402 |
| MNDR | hsa-miR-146a-5p | Kaposi sarcoma | MNDR-E-MI-15403 |
| MNDR | hsa-miR-146a-5p | Dementia vascular | MNDR-E-MI-15404 |
| MNDR | hsa-miR-146a-5p | Crohn disease | MNDR-E-MI-15405 |
| MNDR | hsa-miR-146a-5p | Tonsil cancer | MNDR-E-MI-15406 |
| MNDR | hsa-miR-146a-5p | Neuromyelitis optica | MNDR-E-MI-15407 |
| MNDR | hsa-miR-146a-5p | Psoriasis | MNDR-E-MI-15408 |
| MNDR | hsa-miR-146a-5p | Skin cutaneous melanoma | MNDR-E-MI-15409 |
| MNDR | hsa-miR-146a-5p | Skin melanoma | MNDR-E-MI-15410 |
| MNDR | hsa-miR-146a-5p | Subacute sclerosing panencephalitis | MNDR-E-MI-15411 |
| MNDR | hsa-miR-146a-5p | Acute myelocytic leukemia | MNDR-E-MI-15412 |
| MNDR | hsa-miR-146a-5p | Colorectal cancer | MNDR-E-MI-15413 |
| MNDR | hsa-miR-146a-5p | Type 2 diabetes mellitus | MNDR-E-MI-15414 |
| MNDR | hsa-miR-146a-5p | Diabetic neuropathy | MNDR-E-MI-15415 |
| MNDR | hsa-miR-146a-5p | Acute lymphocytic leukemia | MNDR-E-MI-15416 |
| MNDR | hsa-miR-146a-5p | Seizures febrile | MNDR-E-MI-15417 |
| MNDR | hsa-miR-146a-5p | Ependymoma | MNDR-E-MI-15418 |
| MNDR | hsa-miR-146a-5p | Graft vs host disease | MNDR-E-MI-15419 |
| MNDR | hsa-miR-146a-5p | Cardiomegaly | MNDR-E-MI-15420 |
| MNDR | hsa-miR-146a-5p | Nasopharyngeal cancer | MNDR-E-MI-15421 |
| MNDR | hsa-miR-146a-5p | Prostatic neoplasms | MNDR-E-MI-15422 |
| MNDR | hsa-miR-146a-5p | Wounds and injuries | MNDR-E-MI-15423 |
| MNDR | hsa-miR-146a-5p | Muscle weakness | MNDR-E-MI-15424 |
| MNDR | hsa-miR-146a-5p | Epstein-barr virus infections | MNDR-E-MI-15425 |
| MNDR | hsa-miR-146a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-15426 |
| MNDR | hsa-miR-146a-5p | Gait ataxia | MNDR-E-MI-15427 |
| MNDR | hsa-miR-146a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-15428 |
| MNDR | hsa-miR-146a-5p | Stroke | MNDR-E-MI-15429 |
| MNDR | hsa-miR-146a-5p | Encephalitis herpes simplex | MNDR-E-MI-15430 |
| MNDR | hsa-miR-146a-5p | Nk/t cell lymphoma | MNDR-E-MI-15431 |
| MNDR | hsa-miR-146a-5p | Stroke lacunar | MNDR-E-MI-15432 |
| MNDR | hsa-miR-146a-5p | Breast cancer her3+ negative | MNDR-E-MI-15433 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL2 | Homo sapiens | RR00027153 |
TOP